Table 4.
Univariate analysis |
Multivariate analysis |
|||||
---|---|---|---|---|---|---|
β | 95%CI | p | β | 95%CI | p | |
Age | 0.024 | 0.017–0.032 | <.001 | 0.018 | 0.011–0.024 | <.001 |
Sex | 0.062 | −0.201 to 0.324 | .643 | |||
PD duration | 0.008 | 0.003–0014 | .004 | |||
History of diabetes | 0.315 | 0.019–0.611 | .037 | |||
BMI (kg/m2) | 0.038 | 0.005–0.072 | .024 | |||
Use of statins | 0.417 | 0.159–0.674 | .002 | |||
Albumin (g/L) | −0.019 | −0.036 to 0.002 | .031 | |||
FBG (mmol/L) | 0.159 | 0.092–0.226 | <.001 | 0.092 | 0.034–0.151 | .002 |
CHO (mmol/L) | 0.144 | 0.014–0.273 | .030 | 0.136 | 0.028–0.244 | .013 |
ApoB(g/L) | 0.992 | 0.235–1.749 | .010 | |||
hsCRP (mg/L) | 0.074 | 0.056–0.092 | <.001 | 0.061 | 0.045–0.078 | <.001 |
nPCR (g/kg/24 h) | −1.059 | −1.626 to 0.492 | <.001 | |||
Residual renal Kt/V | −0.274 | −0.513 to 0.034 | .025 |
BMI: body mass index; FBG: fasting blood glucose; CHO: cholesterol; ApoB: apolipoprotein B; hsCRP: high-sensitivity C-reactive protein; nPCR: normalized protein catabolic rate.
Data are expressed as regression coefficient (β) and p value.